Sun Pharma eyes biosimilars-led growth, Organon deal to build $12.4 billion global platform

On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals

Lupin Manufacturing Solutions announces expansion of Dabhasa facility

These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions

Suven Pharmaceuticals get final approval to amalgamate Cohance Lifesciences

The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations

Bionova opens Fremont process development and pilot plant

Lonza outlines strategy, new organizational structure and guidance

The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities

Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms

The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking